Page 8 - Michael Yu News Today

/PRNewswire/ -- Altitude Lab today announced its first cohort of startups raised $54M in seed funding while incubating at Altitude Lab. Founded by Recursion®...

/PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...

A tattooed Asian male on Feb. 10 attacked two information booths in New York City’s Flushing, which were ...

It was July 20, 1999. Michael Yu, an accountant and Falun Gong practitioner remembers what happened in China well. Then Chinese President Jiang Zemin had declared millions of Yu’s fellow Falun Gong practitioners a threat to the government. A warrant was also issued for the arrest of Li Hongzhi who had founded the spiritual movement only seven years earlier in 1992.

It was July 20, 1999. Michael Yu, an accountant and Falun Gong practitioner remembers what happened in China well. Then Chinese President Jiang Zemin had declared millions of Yu’s fellow Falun Gong practitioners a threat to the government. A warrant was also issued for the arrest of Li Hongzhi who had founded the spiritual movement only seven years earlier in 1992.

It was July 20, 1999. Michael Yu, an accountant and Falun Gong practitioner remembers what happened in China well. Then Chinese President Jiang Zemin had declared millions of Yu’s fellow Falun Gong practitioners a threat to the government. A warrant was also issued for the arrest of Li Hongzhi who had founded the spiritual movement only seven years earlier in 1992.

Weeks after signaling it could no longer go on, the troubled Chinese property developer has pledged to start paying its workers and completing projects again. Buyers are skeptical.

China’s pharmaceutical sector, long known for generic drugs and raw materials, is rapidly emerging as a force in innovative medicines. This dovetails with Beijing’s ambition to surpass the U.S. industry, especially in biologics. China’s methods, however, have drawn significant criticism.

/PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...

/PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...